# Xilio Therapeutics (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/xilio-therapeutics-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 59 |
| Citations | 8,832 |
| City | Waltham |
| Country | United States |
| Description | Xilio Therapeutics (United States) is a research organisation in Waltham, United States. OpenAlex records 90 works and 8,832 citations for it. 1 researchers list it as their most recent affiliation. |
| Homepage | https://xiliotx.com |
| OpenAlex ID | https://openalex.org/I4210164253 |
| Region | Massachusetts |
| Researchers | 1 |
| ROR ID | https://ror.org/05fn2nj53 |
| Type | company |
| Works | 90 |

## University papers

- [Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer](https://scholariq.org/papers/anaplastic-lymphoma-kinase-inhibition-in-non-small-cell-lung-cancer/)
- [Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)](https://scholariq.org/papers/cutaneous-keratoacanthomas-squamous-cell-carcinomas-associated-with/)

## University researchers

- [Bruce J. Dezube](https://scholariq.org/researchers/bruce-j-dezube/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.